Some time in the late 30s or 40s, many senior consultants in private practice receive an offer from a hospital they have been associated with: come on board as a partner. The offer is usually presented as recognition of seniority, a path to longer-term clinical leadership, and an opportunity to share in the financial upside of an institution they have helped build. The doctor, flattered and often genuinely committed to the hospital, accepts.
The decision is one of the largest financial commitments a doctor makes in their career. It is rarely analysed as one.
What the partnership actually involves
Hospital partnership offers vary widely, but most fall into two structural categories.
1. Equity partnership in a private hospital LLP or company. The doctor buys (or is allocated) a defined percentage stake. They contribute capital — sometimes through a buy-in, sometimes through deferred salary, sometimes both. They receive a share of profit distributions, governance rights proportional to their stake, and exposure to the hospital's exit value if it is ever sold.
2. Profit-sharing arrangement, without formal equity. The doctor receives an enhanced share of the revenues they generate, sometimes layered with a hospital-wide bonus. There is no capital lock-in; rights are typically contractual, not ownership-based.
The two are radically different. The first is an investment. The second is a compensation arrangement. Many doctors confuse them, especially when offered orally in a conversation with a hospital's owners.
What an equity partnership actually buys
A genuine equity stake in a private hospital is a private investment with a specific risk profile. Returns come from two sources:
- Annual profit distributions, typically 8-15% on equity capital in a well-run multi-specialty hospital, sometimes higher in a specialised facility, sometimes near zero or negative in a struggling one.
- Capital appreciation on exit, if the hospital is acquired, listed, or sold to a strategic. Indian hospital exits over the past decade have produced wide-dispersion outcomes — some excellent, many modest, several disappointing.
The total return, over a hold period of 8-15 years, has historically averaged something close to broad listed equity returns, with substantially more volatility, much more illiquidity, and more concentration risk.
The doctor evaluating an offer should hold this in mind: the partnership is an investment in a specific private business, not a guaranteed wealth multiplier.
The five questions a doctor should ask before accepting
In our work with doctors offered hospital partnerships, we walk through five questions.
1. What is the valuation? Hospitals are sometimes offered at valuations that are reasonable, sometimes at valuations that are aggressive, occasionally at valuations that look reasonable on paper but are inflated by accounting treatment of certain assets. The doctor's first job is to understand what they are paying, and against what underlying revenue and EBITDA — not just last year's, but the trend.
2. What is the doctor's lock-in, and what are the exit mechanics? Most hospital partnerships have multi-year lock-ins, restrictive transfer clauses, and unclear exit valuations. The doctor needs to know — in writing — how they exit if they want to, what valuation method applies, and how long the process takes.
3. How is governance structured? What proportion of the equity does the doctor's stake translate into voting rights? On what decisions does the doctor have a say? Many hospital partnerships are nominally equity but practically powerless — the founding owners retain decision rights through articles, side agreements, or simple majority dynamics.
4. What is the doctor's expected income from the partnership, in addition to their clinical earnings? And how does that compare to the opportunity cost of the capital — what the same money would have earned in a diversified portfolio over the same lock-in period?
5. What is the doctor's concentration exposure? A doctor whose career income depends on the same hospital they have invested in is doubly exposed. If the hospital underperforms, both the doctor's clinical work and their investment suffer simultaneously. This is the single most under-discussed risk in hospital partnerships.
When the partnership genuinely makes sense
There are situations where the partnership offer is the right answer.
- A well-run hospital, fairly valued, with clear governance, where the doctor will play a meaningful clinical-leadership role for the next 10-15 years.
- A hospital where the doctor's continued involvement is itself a major driver of value, and where partnership formalises an arrangement that already exists in substance.
- A hospital with a credible exit thesis — a likely strategic acquisition, a clear path to listing, a well-priced buy-back option — that aligns with the doctor's own time horizon.
In these cases, partnership is not just a financial decision; it is also a career step that organises the doctor's professional life for a long period.
When it does not make sense
Equally clear are the situations where doctors should pause.
- When the offer is tied to a specific volume of clinical work the doctor must commit to, effectively converting partnership into a contractual obligation. This is common and often poorly disclosed.
- When the doctor is being asked to fund a meaningful portion of the buy-in, with personal credit or personal capital, into a single concentrated investment.
- When the hospital's financials are not made fully available, or are presented selectively. A partnership offered without full financial disclosure is, almost by definition, not a partnership.
- When the doctor is already heavily invested in real estate or other illiquid assets, and the hospital partnership would push the family balance sheet further into illiquidity.
The work of the decision
A real evaluation of a hospital partnership offer takes 4-8 weeks of work — financial review, legal review, governance review, opportunity-cost analysis. Most doctors do not invest this time. They assess the offer in conversation, in social context, with the hospital owners they trust. They sign within days or weeks.
The right discipline is to treat the decision the way one would treat any private equity commitment of equivalent size. Decline to commit until the diligence is done. Insist on financials, lock-in clauses, and governance terms in writing. Run the math honestly. Ask whether, removing the relationship dimension, this is still an investment the doctor would make.
In our experience, the careful evaluation either strengthens the conviction in the partnership — confirming it is a sound decision — or surfaces issues that, addressed pre-signing, materially improve the terms. The post-decision discovery of those same issues is, almost always, more expensive than the pre-decision diligence.
We send only when there's something worth saying — typically once or twice a month.